enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prostate-specific antigen - Wikipedia

   en.wikipedia.org/wiki/Prostate-specific_antigen

   However, the PSA rate of rise may have value in prostate cancer prognosis. Men with prostate cancer whose PSA level increased by more than 2.0 ng per milliliter during the year before the diagnosis of prostate cancer have a higher risk of death from prostate cancer despite undergoing radical prostatectomy. [62]

3. New prostate cancer imaging shows ‘extremely encouraging ...

   www.aol.com/prostate-cancer-imaging-shows...

   Researchers say the current means of testing, called a prostate specific antigen (PSA), is unreliable and means men are sent for expensive MRI scans which can come with long waiting lists ...

4. List of people with prostate cancer - Wikipedia

   en.wikipedia.org/wiki/List_of_people_with...

   American baseball player (diagnosed with early stage prostate cancer after a PSA test at the age of 55 in 2006. He subsequently underwent successful surgery for his cancer. Griffey Sr. revealed that prostate cancer was hereditary in his family, with four of his uncles suffering from the disease) [680] [681] Happy Hairston: 1942 – 2001

5. Reference ranges for blood tests - Wikipedia

   en.wikipedia.org/wiki/Reference_ranges_for_blood...

   3.5, [5] [14] 3.6 [15] 5.0, ... Hepatocellular carcinoma or testicular cancer ... Prostate specific antigen (PSA) 40–49 years: 1.2–2.9 [75]

6. Anthony Peter Lowe - Wikipedia

   en.wikipedia.org/wiki/Anthony_Peter_Lowe

   The guidelines were highlighted by Cancer Council Australia and PCFA to build consensus around approaches to PSA testing within Australia's prostate cancer screening program. [26] The guideline recommendations were approved by the chief executive officer of NHMRC and published in January 2016.

7. Comparison of bicalutamide with other antiandrogens

   en.wikipedia.org/wiki/Comparison_of_bicalutamide...

   [78] [79] [80] Of the SAAs, CPA is the only one that has been widely used in the treatment of prostate cancer. [28]: 488 As antiandrogens, the SAAs have largely been replaced by the NSAAs and are now rarely used in the treatment of prostate cancer, due to the superior selectivity, efficacy, and tolerability profiles of NSAAs.